Birmingham, MI (PRWEB) November 01, 2012
Only CureLauncher.com translates the complex, medical terminology into easy to understand English. It provides the entry questions to determine if a clinical trial is appropriate for anyone’s specific condition. People can submit a Request Form to participate in the trial or call CureLauncher directly to see if they qualify. CureLauncher is free to all users and a concierge person is available to answer any questions.
This remarkable information tool instantly helps people connect with clinical trials that can save their life.
CureLauncher is dedicated to funding NIH-caliber drug and medical device research. Founder and President Stephen Goldner, JD, RAC introduced this service at the MAGI Clinical Research Conference in San Diego, October 21st – 24th. “This MAGI Clinical Trials gathering represents medical treatment and hope for thousands of people suffering from disease who don’t know where to turn. We are proud to support these medical teams to treat every person afflicted with breast cancer and other diseases”.
Mr. Goldner’s seminar at the MAGI Conference was based on his 40 years of experience getting FDA and worldwide approvals to make safer and more effective healthcare products. He is the Founder of Regulatory Affairs Associates, FDA consultants to the National Institutes of Health in Bethesda, MD.
CureLauncher connects people to world-class drug and medical device inventors. This month’s featured project is a new metastatic breast cancer treatment from esteemed cancer researcher Dr. Lee Roy Morgan, CEO of DEKK-TEC, Inc. Each person who donates $25 or more to Dr. Morgan’s research on CureLauncer.com can write a personal and confidential email and receive Dr. Morgan's reply.
Mr. Goldner’s regulatory expertise and credibility make CureLauncher the preferred source to connect people to clinical trials that can save their life. “CureLauncher addresses the current need to provide easy access for people to get clinical treatment and feel connected to a community of supporters,” said Vice President David Fuehrer.
To learn more, visit http://www.curelauncher.com
CureLauncher is dedicated to funding NIH-caliber drug and medical device research. This online community enables people to find and fund medical research in a way never before possible. Advocates of the research interact with each other and leading medical professionals to generate support. CureLauncher provides funding for new drug and medical device researchers to bring lifesaving treatments to people who need them.
Find It. Fund It. Cure It.